Readthrough isoform of aquaporin-4 (AQP4) as a therapeutic target for Alzheimer's disease and other proteinopathies.

Mohaupt, Pablo; Vialaret, Jérôme; Hirtz, Christophe; Lehmann, Sylvain

Mohaupt, Pablo; Vialaret, Jérôme; Hirtz, Christophe; Lehmann, Sylvain.

Affiliation

Mohaupt P; LBPC-PPC, Université de Montpellier, IRMB CHU de Montpellier, INM INSERM, Montpellier, France.
Vialaret J; LBPC-PPC, Université de Montpellier, IRMB CHU de Montpellier, INM INSERM, Montpellier, France.
Hirtz C; LBPC-PPC, Université de Montpellier, IRMB CHU de Montpellier, INM INSERM, Montpellier, France. christophe.hirtz@umontpellier.fr.
Lehmann S; LBPC-PPC, Université de Montpellier, IRMB CHU de Montpellier, INM INSERM, Montpellier, France.

Alzheimers Res Ther ; 15(1): 170, 2023 10 11.

Article in En | MEDLINE | ID: mdl-37821965

Subject(s)

Alzheimer Disease; Proteostasis Deficiencies; Humans; Alzheimer Disease/metabolism; Amyloid beta-Peptides/metabolism; Aquaporin 4/metabolism; Brain/metabolism; Protein Isoforms/metabolism; Proteostasis Deficiencies/metabolism

Key words

Alzheimer's; Aquaporin-4; Protein aggregation; Proteinopathies; Therapeutic target; Waste clearance

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteostasis Deficiencies / Alzheimer Disease Limits: Humans Language: En Journal: Alzheimers Res Ther Year: 2023 Document type: Article Affiliation country: France Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google